<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-113953</identifier>
<setSpec>1138-3593</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Renal cell carcinoma producing erythrocytosis due to inappropriate production of erythropoietin</dc:title>
<dc:description xml:lang="en">Erythrocytosis, or polycythaemia, is an increase, in absolute terms, of the erythrocyte mass. The most common solid tumour related to this phenomenon is renal cell carcinoma, which can produce erythrocytosis by increasing erythropoietin production. About 30% of symptomatic renal cell carcinomas are diagnosed due to the appearance of a paraneoplastic syndrome. Polycythaemia is one of these. Surgery, (radical or partial nephrectomy), is the treatment of choice in renal cell carcinoma and helps to keep the erythrocytosis situation under control (AU)</dc:description>
<dc:creator>Vicario-Bermúdez, J. M</dc:creator>
<dc:creator>Villanueva-Gimeno, M. M</dc:creator>
<dc:creator>Caballero-Castro, J. P</dc:creator>
<dc:creator>Sánchez-Elipe, M. A</dc:creator>
<dc:creator>González-Gómez, N</dc:creator>
<dc:creator>Fonseca-López, C. H</dc:creator>
<dc:creator>Zabala-López, S. I</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La eritrocitosis o poliglobulia es el aumento, en términos absolutos, de la masa eritrocitaria. El tumor sólido que con más frecuencia se asocia a este fenómeno es el carcinoma de células renales, que puede producir eritrocitosis a expensas del aumento de síntesis de eritropoyetina. Sobre el 30% de los CCR se diagnostican a partir de un síndrome paraneoplásico, entre los que está descrita la poliglobulia. La cirugía, (nefrectomía radical o parcial), es el principal pilar en el tratamiento de esta enfermedad y permite corregir la situación de eritrocitosis (AU)</dc:description>
<dc:source>SEMERGEN, Soc. Esp. Med. Rural Gen. (Ed. Impr.);39(5): 282-284, jul.-ago. 2013.</dc:source>
<dc:identifier>ibc-113953</dc:identifier>
<dc:title xml:lang="es">Eritrocitosis secundaria a la producción inapropiada de eritropoyetina por un carcinoma de células renales</dc:title>
<dc:subject>^d11520^s22012</dc:subject>
<dc:subject>^d24339^s22045</dc:subject>
<dc:subject>^d7849^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d9585^s22066</dc:subject>
<dc:subject>^d9585^s22045</dc:subject>
<dc:subject>^d7849^s22012</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d9585^s22074</dc:subject>
<dc:subject>^d11756^s22074</dc:subject>
<dc:subject>^d2335^s22009</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d24339^s22039</dc:subject>
<dc:subject>^d2335^s22016</dc:subject>
<dc:subject>^d11520^s22016</dc:subject>
<dc:subject>^d11756^s22045</dc:subject>
<dc:subject>^d2335^s29166</dc:subject>
<dc:subject>^d2335^s22032</dc:subject>
<dc:subject>^d2335^s22012</dc:subject>
<dc:type>article</dc:type>
<dc:date>201308</dc:date>
</metadata>
</record>
</ibecs-document>
